583 related articles for article (PubMed ID: 12225700)
1. SR46349-B, a 5-HT(2A/2C) receptor antagonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
Bonaccorso S; Meltzer HY; Li Z; Dai J; Alboszta AR; Ichikawa J
Neuropsychopharmacology; 2002 Sep; 27(3):430-41. PubMed ID: 12225700
[TBL] [Abstract][Full Text] [Related]
2. ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
Li Z; Ichikawa J; Huang M; Prus AJ; Dai J; Meltzer HY
Psychopharmacology (Berl); 2005 Dec; 183(2):144-53. PubMed ID: 16220333
[TBL] [Abstract][Full Text] [Related]
3. 5-HT(2A) receptor antagonism potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and inhibits that in the nucleus accumbens in a dose-dependent manner.
Liégeois JF; Ichikawa J; Meltzer HY
Brain Res; 2002 Aug; 947(2):157-65. PubMed ID: 12176156
[TBL] [Abstract][Full Text] [Related]
4. 5-HT(1A) and 5-HT(2A) receptors minimally contribute to clozapine-induced acetylcholine release in rat medial prefrontal cortex.
Ichikawa J; Dai J; Meltzer HY
Brain Res; 2002 Jun; 939(1-2):34-42. PubMed ID: 12020849
[TBL] [Abstract][Full Text] [Related]
5. R(+)-8-OH-DPAT, a serotonin(1A) receptor agonist, potentiated S(-)-sulpiride-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens but not striatum.
Ichikawa J; Meltzer HY
J Pharmacol Exp Ther; 1999 Dec; 291(3):1227-32. PubMed ID: 10565846
[TBL] [Abstract][Full Text] [Related]
6. The effect of serotonin(1A) receptor agonism on antipsychotic drug-induced dopamine release in rat striatum and nucleus accumbens.
Ichikawa J; Meltzer HY
Brain Res; 2000 Mar; 858(2):252-63. PubMed ID: 10708676
[TBL] [Abstract][Full Text] [Related]
7. Lithium differs from anticonvulsant mood stabilizers in prefrontal cortical and accumbal dopamine release: role of 5-HT(1A) receptor agonism.
Ichikawa J; Dai J; Meltzer HY
Brain Res; 2005 Jul; 1049(2):182-90. PubMed ID: 15936730
[TBL] [Abstract][Full Text] [Related]
8. 5-HT 2A receptor stimulation by DOI, a 5-HT 2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
Kuroki T; Meltzer HY; Ichikawa J
Brain Res; 2003 May; 972(1-2):216-21. PubMed ID: 12711095
[TBL] [Abstract][Full Text] [Related]
9. In vivo evidence that constitutive activity of serotonin2C receptors in the medial prefrontal cortex participates in the control of dopamine release in the rat nucleus accumbens: differential effects of inverse agonist versus antagonist.
Leggio GM; Cathala A; Neny M; Rouge-Pont F; Drago F; Piazza PV; Spampinato U
J Neurochem; 2009 Oct; 111(2):614-23. PubMed ID: 19702657
[TBL] [Abstract][Full Text] [Related]
10. Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism.
Ichikawa J; Li Z; Dai J; Meltzer HY
Brain Res; 2002 Nov; 956(2):349-57. PubMed ID: 12445705
[TBL] [Abstract][Full Text] [Related]
11. 5-HT6 receptor antagonist SB-399885 potentiates haloperidol and risperidone-induced dopamine efflux in the medial prefrontal cortex or hippocampus.
Li Z; Huang M; Prus AJ; Dai J; Meltzer HY
Brain Res; 2007 Feb; 1134(1):70-8. PubMed ID: 17207474
[TBL] [Abstract][Full Text] [Related]
12. Effect of antipsychotic drugs on extracellular serotonin levels in rat medial prefrontal cortex and nucleus accumbens.
Ichikawa J; Kuroki T; Dai J; Meltzer HY
Eur J Pharmacol; 1998 Jun; 351(2):163-71. PubMed ID: 9686999
[TBL] [Abstract][Full Text] [Related]
13. The effect of serotonergic agents on haloperidol-induced striatal dopamine release in vivo: opposite role of 5-HT(2A) and 5-HT(2C) receptor subtypes and significance of the haloperidol dose used.
Lucas G; De Deurwaerdère P; Caccia S; Umberto Spampinato
Neuropharmacology; 2000 Apr; 39(6):1053-63. PubMed ID: 10727716
[TBL] [Abstract][Full Text] [Related]
14. In vivo evidence that 5-HT2C receptor antagonist but not agonist modulates cocaine-induced dopamine outflow in the rat nucleus accumbens and striatum.
Navailles S; De Deurwaerdère P; Porras G; Spampinato U
Neuropsychopharmacology; 2004 Feb; 29(2):319-26. PubMed ID: 14560323
[TBL] [Abstract][Full Text] [Related]
15. Antagonism at 5-HT(2A) receptors potentiates the effect of haloperidol in a conditioned avoidance response task in rats.
Wadenberg MG; Browning JL; Young KA; Hicks PB
Pharmacol Biochem Behav; 2001 Mar; 68(3):363-70. PubMed ID: 11325387
[TBL] [Abstract][Full Text] [Related]
16. DOI, a 5-HT2A/2C receptor agonist, attenuates clozapine-induced cortical dopamine release.
Ichikawa J; Dai J; Meltzer HY
Brain Res; 2001 Jul; 907(1-2):151-5. PubMed ID: 11430898
[TBL] [Abstract][Full Text] [Related]
17. M100,907, a selective 5-HT(2A) antagonist, attenuates dopamine release in the rat medial prefrontal cortex.
Pehek EA; McFarlane HG; Maguschak K; Price B; Pluto CP
Brain Res; 2001 Jan; 888(1):51-59. PubMed ID: 11146051
[TBL] [Abstract][Full Text] [Related]
18. Antagonizing 5-HT₂A receptors with M100907 and stimulating 5-HT₂C receptors with Ro60-0175 blocks cocaine-induced locomotion and zif268 mRNA expression in Sprague-Dawley rats.
Burton CL; Rizos Z; Diwan M; Nobrega JN; Fletcher PJ
Behav Brain Res; 2013 Mar; 240():171-81. PubMed ID: 23201361
[TBL] [Abstract][Full Text] [Related]
19. Serotonin2C receptors in the medial prefrontal cortex facilitate cocaine-induced dopamine release in the rat nucleus accumbens.
Leggio GM; Cathala A; Moison D; Cunningham KA; Piazza PV; Spampinato U
Neuropharmacology; 2009 Feb; 56(2):507-13. PubMed ID: 18977370
[TBL] [Abstract][Full Text] [Related]
20. Effect of sertindole on extracellular dopamine, acetylcholine, and glutamate in the medial prefrontal cortex of conscious rats: a comparison with risperidone and exploration of mechanisms involved.
Mørk A; Witten LM; Arnt J
Psychopharmacology (Berl); 2009 Sep; 206(1):39-49. PubMed ID: 19506838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
